Literature DB >> 26475946

Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond.

Daniel P Boyle1, Teresa R Zembower2.   

Abstract

Worldwide prevalence of antimicrobial resistance is rapidly increasing, primarily a result of antibiotic misuse in the medical community. Resistant infections involving the urinary tract are typically caused by gram-negative bacteria. When treating these infections, clinicians have few effective antimicrobials to choose from and many are associated with significant adverse effects. There are now situations when clinicians are tasked with managing infections from pan-resistant organisms; thus, it is of paramount importance that spread of resistance be controlled. This review discusses common gram-negative resistance classes, highlighting the mechanisms of resistance, risk factors, type of infections, treatment, and outcomes associated with each class.
Copyright © 2015 Elsevier Inc. All rights reserved.

Keywords:  Antibiotic resistance; Carbapenem-resistant Acinetobacter baumannii; Carbapenem-resistant enterobacteriaceae; Extended-spectrum β-lactamases; Multidrug-resistant Pseudomonas aeruginosa; New Delhi metallo–β-lactamase

Mesh:

Substances:

Year:  2015        PMID: 26475946     DOI: 10.1016/j.ucl.2015.05.005

Source DB:  PubMed          Journal:  Urol Clin North Am        ISSN: 0094-0143            Impact factor:   2.241


  11 in total

1.  Antibacterial Efficacy of Eravacycline In Vivo against Gram-Positive and Gram-Negative Organisms.

Authors:  Marguerite L Monogue; Abrar K Thabit; Yukihiro Hamada; David P Nicolau
Journal:  Antimicrob Agents Chemother       Date:  2016-07-22       Impact factor: 5.191

2.  Establishment of a Simple and Quick Method for Detecting Extended-Spectrum β-Lactamase (ESBL) Genes in Bacteria.

Authors:  Song-Tao Han; Ying Fei; Jin-You Huang; Mei Xu; Li-Chan Chen; D Joshua Liao; Yu-Jie Tan
Journal:  J Biomol Tech       Date:  2016-09-16

3.  Genomic and Biochemical Characterization of Acinetobacter Podophage Petty Reveals a Novel Lysis Mechanism and Tail-Associated Depolymerase Activity.

Authors:  A C Hernandez-Morales; L L Lessor; T L Wood; D Migl; E M Mijalis; J Cahill; W K Russell; R F Young; J J Gill
Journal:  J Virol       Date:  2018-02-26       Impact factor: 5.103

Review 4.  Klebsiella pneumoniae: Going on the Offense with a Strong Defense.

Authors:  Michelle K Paczosa; Joan Mecsas
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-15       Impact factor: 11.056

5.  Ribaxamase, an Orally Administered β-Lactamase, Diminishes Changes to Acquired Antimicrobial Resistance of the Gut Resistome in Patients Treated with Ceftriaxone.

Authors:  John F Kokai-Kun; Chenxiong Le; Kenneth Trout; Julia L Cope; Nadim J Ajami; Andrew J Degar; Sheila Connelly
Journal:  Infect Drug Resist       Date:  2020-07-22       Impact factor: 4.003

Review 6.  Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.

Authors:  Mahmood Al-Orphaly; Hamad Abdel Hadi; Faiha Kamaleldin Eltayeb; Hissa Al-Hail; Bincy Gladson Samuel; Ali A Sultan; Sini Skariah
Journal:  mSphere       Date:  2021-05-19       Impact factor: 4.389

7.  Risk factors for community-associated multidrug-resistant Pseudomonas aeruginosa in veterans with spinal cord injury and disorder: a retrospective cohort study.

Authors:  I O Kale; M A Fitzpatrick; K J Suda; S P Burns; L Poggensee; S Ramanathan; R Sabzwari; C T Evans
Journal:  Spinal Cord       Date:  2017-02-07       Impact factor: 2.772

8.  The Oral β-Lactamase SYN-004 (Ribaxamase) Degrades Ceftriaxone Excreted into the Intestine in Phase 2a Clinical Studies.

Authors:  John F Kokai-Kun; Tracey Roberts; Olivia Coughlin; Eric Sicard; Marianne Rufiange; Richard Fedorak; Christian Carter; Marijke H Adams; James Longstreth; Heidi Whalen; Joseph Sliman
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 9.  Management of bacterial infection in the liver transplant candidate.

Authors:  Alberto Ferrarese; Alberto Zanetto; Chiara Becchetti; Salvatore Stefano Sciarrone; Sarah Shalaby; Giacomo Germani; Martina Gambato; Francesco Paolo Russo; Patrizia Burra; Marco Senzolo
Journal:  World J Hepatol       Date:  2018-02-27

10.  Antibiotic Susceptibility Patterns of Bacterial Isolates from Routine Clinical Specimens from Referral Hospitals in Tanzania: A Prospective Hospital-Based Observational Study.

Authors:  Nicholaus P Mnyambwa; Coline Mahende; Amani Wilfred; Erica Sandi; Nicodem Mgina; Clara Lubinza; Amos Kahwa; Pammla Petrucka; Sayoki Mfinanga; Esther Ngadaya; Godfather Kimaro
Journal:  Infect Drug Resist       Date:  2021-03-03       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.